Artificial intelligence companies are making massive investments, projected to reach nearly $1.1 trillion by 2027, in building AI data centers, necessitating substantial earnings growth for hyperscalers to justify these expenditures. Separately, the OpenAI Foundation is funding the creation of high-quality scientific datasets, specifically targeting biological data, to improve AI's capabilities in areas like disease cure. Discussions are also ongoing about the potential extinction risks posed by advanced AI models and the development of novel drugs for aging.
Read the full article at MIT Tech Review
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
Views7
Ali NematiBlogUI.author_articles
